In Focus

Joint statement on the current epidemics of new Coronavirus

Together with IPOPI, INGID, APSID, ASID, ARAPID, CIS, LASID, SEAPID we have worked on... es

PID Survey update - COVID-19

The Survey summary on COVID-19 in PID patients can be viewed  here. es

IPOPI – ESID Joint Statement: The use of monoclonal antibody treatment for patients with PID in the context of the COVID-19 pandemic

 IPOPI ESID Statement IPOPI – ESID Joint Statement The use of monoclonal antib... es
News

Hyper IgM Grant opportunity

ESID is pleased to announce an excellent grant funding opportunity es

Study on clinical course of IPEX patients infected with SARS-CoV-2

Call for international contributions relating to IPEX patients infected with SARS-CoV-2. es

X-Linked Carrier Survey is now open

The Hyper IgM Foundation and the Wiskott-Aldrich Foundation’s first-ever&nb... es
Events
Shortcuts
Affiliated Societies
Affiliated Societies es
Gothenburg 2022
ESID 2022 Biennial meeting in Gothenburg es
Congress
ESID 2021: The Clinical Working Party Multidisciplinary Symposium es
Registry
ESID Online Registry es
Newsletter
Access ESID’s latest news es